Nasacort Is Safe, Effective in Children Ages 2–5, Sanofi-Aventis Says

FDANews : "New data released by sanofi-aventis show Nasacort AQ is safe and effective in children ages 2–5 with allergic rhinitis and does not affect their adrenal function. Healthcare professionals have been concerned that intranasal corticosteroids, such as Nasacort AQ (triamcinolone acetonide), could affect adrenal function in children, study investigator Anjuli Nayak said. However, results from a clinical trial showed Nasacort AQ did not have a significant effect on adrenal function in children ages 2–5 compared with placebo."